Emergent BioSolutions Inc (EBS)

8.30 +0.15 (+1.84%) USD  |  NYSE  |  Dec 24, 16:00
More

Emergent BioSolutions Cash and Short Term Investments (Quarterly): 149.90M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.788B
Tonix Pharmaceuticals Holding Corp 28.23M
Chimerix Inc 136.23M
Geron Corp 339.77M
MAIA Biotechnology Inc 8.691M